MDAI · XBRL financial data

Spectral AI financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (MDAI's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	3,440	5,287*	6,326	7,478	8,173	7,604*	6,707	5,065	3,792	4,086*	3,991	3,524
Cost of revenue	1,968	2,851*	3,381	4,164	4,506	4,256*	3,539	2,775	2,171	2,240*	1,964	2,411
Gross profit	1,472	2,436*	2,945	3,314	3,667	3,348*	3,168	2,290	1,621	1,846*	2,027	1,113
Research and development	—	year only	4,300	—	—	—	3,600	1,457	2,400*	—	2,000	1,696
General and administrative	5,638	5,365*	5,088	5,756	4,553	4,459*	4,064	4,413	4,962	4,089*	3,998	3,088
Total operating expenses	—	—	—	5,756	4,553	4,459*	4,064	4,413	4,962	4,089*	3,998	5,437
Operating income (loss)	(4,166)	(2,929)*	(2,143)	(2,442)	(886)	(1,111)*	(896)	(2,123)	(3,341)	(2,243)*	(1,971)	(4,324)
Interest income	—	year only	—	—	—	year only	—	—	—	—	—	—
Interest expense	—	—	—	—	8	year only	20	120	300	289*	258	378
Income tax expense (benefit)	(54)	(21)*	22	69	37	143*	71	(19)	2	(43)*	(10)	170
Net income (loss)	(10,629)	(3,546)*	(3,205)	(2,864)	(1,504)	(7,742)*	2,897	(7,968)	(3,552)	1,052*	(3,412)	(4,176)
Earnings per share, basic USD per share	(0.77)	(0.22)*	(0.19)	(0.16)	(0.08)	(0.39)*	0.13	(0.31)	(0.13)	0.03*	(0.11)	(0.13)
Earnings per share, diluted USD per share	(0.77)	(0.22)*	(0.19)	(0.16)	(0.08)	(0.39)*	0.11	(0.31)	(0.13)	0.03*	(0.11)	(0.13)
Weighted average shares, basic thousands of shares	13,823	16,097*	16,560	17,598	17,862	19,697*	22,986	25,422	26,319	31,259*	31,757	32,081
Weighted average shares, diluted thousands of shares	13,823	16,097*	16,560	17,598	17,862	19,697*	24,031	25,422	26,319	30,237*	31,757	32,081

Balance sheet

CSV

Fiscal quarters (MDAI's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	7,348	4,790	10,157	6,877	3,702	5,200	14,100	10,500	10,500	15,400	11,700	14,000
Accounts receivable	1,312	2,346	1,828	2,295	2,834	2,505	2,103	1,467	990	1,267	1,185	1,181
Inventory	220	230	228	267	443	425	437	462	454	838	831	815
Total current assets	11,356	9,902	14,884	11,661	9,496	10,122	18,728	14,001	13,463	19,453	15,986	17,792
Property and equipment, net	14	12	9	7	5	2	164	317	287	258	228	198
Right-of-use asset	961	778	590	2,229	2,101	1,971	1,830	1,691	1,550	1,407	1,260	1,109
Total assets	12,331	10,692	15,483	13,897	11,602	12,095	20,722	16,009	15,300	21,405	17,734	19,436
Accounts payable	3,275	2,683	3,306	2,403	2,797	4,035	3,113	1,986	2,538	3,010	1,422	1,725
Accrued liabilities	3,983	4,300	3,818	2,733	3,253	3,210	3,712	2,547	2,475	2,341	2,649	1,708
Total current liabilities	10,647	12,401	17,511	16,126	13,068	17,644	13,312	16,186	15,765	20,626	21,273	19,869
Long-term debt	—	—	—	—	—	—	7,512	7,632	6,581	5,538	4,502	11,055
Lease liability, non-current	228	—	—	2,036	1,870	1,702	1,524	1,342	1,157	968	769	566
Total liabilities	10,875	12,401	17,511	18,162	15,938	19,346	22,348	25,160	23,503	27,132	26,544	31,490
Accumulated deficit	(29,242)	(32,788)	(35,993)	(38,857)	(40,361)	(48,103)	(45,332)	(53,300)	(56,852)	(55,800)	(59,212)	(63,388)
Total stockholders' equity	1,456	(1,709)	(2,028)	(4,265)	(4,336)	(7,251)	(1,626)	(9,151)	(8,203)	(5,727)	(8,810)	(12,054)
Total liabilities and equity	12,331	10,692	15,483	13,897	11,602	12,095	20,722	16,009	15,300	21,405	17,734	19,436
Common shares outstanding (cover page) thousands of shares	16,255	17,467	17,482	17,606	18,588	25,317	25,748	26,731	30,689	31,824	31,824	32,185

Cash flows

CSV

Fiscal quarters (MDAI's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(10,629)	(3,546)*	(3,205)	(2,864)	(1,504)	(7,742)*	2,897	(7,968)	(3,552)	1,052*	(3,412)	(4,176)
Stock-based compensation	279*	268*	283	402*	173*	174*	200	411*	261*	243*	183	807*
Net cash from operating activities	(10,489)*	(2,375)*	(2,680)	(5,362)*	(1,626)*	469*	(1,505)	(3,362)*	(2,501)*	(2,552)*	(3,728)	(4,097)*
Proceeds from issuing common stock	—	0*	2,667	0*	0*	1,393*	3,080	0*	0*	7,558*	—	—
Net cash from financing activities	4,520*	(195)*	8,049	2,082*	(1,564)*	1,008*	10,392	(207)*	2,485*	7,450*	(1)	6,423*
Net change in cash	(6,450)*	(2,558)*	5,367	(3,280)*	(3,175)*	1,455*	8,904	(3,537)*	(29)*	4,899*	(3,739)	2,325*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Spectral AI	14,000	3,524	(4,097)*	32.2M	3.4 quarters	Q2 FY26 10-QJun 30, 2026
Sensus Healthcare	15,186	2,290	(3,133)*	16.5M	4.8 quarters	Q2 FY26 10-QJun 30, 2026
CapsoVision	not reported	3,643	(8,403)*	50.0M	—	Q2 FY26 10-QJun 30, 2026
enVVeno Medical	2,585	not reported	(3,178)*	694,826	5.6 quarters	Q3 FY26 10-QSep 30, 2026
Pro Dex	11,759	20,560	6,490	3.2M	—	Q1 FY27 10-QSep 30, 2026
TELA Bio	30,424	19,291	(9,381)*	44.9M	3.2 quarters	Q2 FY26 10-QJun 30, 2026
Apyx Medical	27,617	13,884	(3,490)*	42.1M	7.9 quarters	Q2 FY26 10-QJun 30, 2026
Orchestra BioMed Holdings	20,472	88	(19,332)*	60.1M	5.7 quarters	Q2 FY26 10-QJun 30, 2026
Lucid Diagnostics	33,404	not reported	(11,297)*	203.2M	3.0 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.